oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Egoropal

The product does not meet quality requirements due to a negative test result for the particle size analysis parameter, which is critical for the safety and efficacy of an injectable suspension. Potencjalne skutki: lack of treatment efficacy, adverse reactions, complications after injection.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Egoropal
Risk Level
Critical
Manufacturer
Egis Pharmaceuticals PLC z siedzibą w Budapeszcie, Węgry
Batch Number
4201475
EAN Code
05995327188706
Recall Date
12.10.2023
View official statement

Important Information

What You Should Know

Recommendations

Do not use this medicinal product; patients should consult a doctor or pharmacist to obtain alternative therapy and check whether the product they hold is subject to the suspension of distribution.

Actions Taken

The Chief Pharmaceutical Inspector suspended the distribution of the medicinal product Egoropal (Paliperidone), prolonged-release suspension for injection, 75 mg, throughout the country and granted th...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: The product does not meet quality requirements due to a negative test result for the particle size analysis parameter, which is critical for the safety and efficacy of an injectable suspension. Potencjalne skutki: lack of treatment efficacy, adverse reactions, complications after injection.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 4201475

Related

Other Recalled Products